| abstract |
Provided in the present invention is an immunomodulator, wherein same falls within the field of medicinal chemistry. The immunomodulator is a compound as shown in formula I, or a stereoisomer thereof, or a salt thereof, or a solvate thereof, or a prodrug thereof, or a metabolite thereof. The present compound exhibits a good IL-17A inhibitory activity, can be used for preparing an IL-17A inhibitor and for the treatment of diseases associated with the abnormal activity of IL-17A, and provides a new medicinal possibility for the clinical treatment of diseases associated with the abnormal activity of IL-17A. |